TTRX · Company research
Turn Therapeutics Inc. (TTRX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
18records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Turn Therapeutics (NASDAQ:TTRX) Cut to "Sell" at Wall Street Zen - MarketBeat | Turn Therapeutics (NASDAQ:TTRX) Cut to "Sell" at Wall Street Zen MarketBeat | View source ↗ | MarketBeat | Oct 18, 2026 | neutral | 0 | 0.6 |
| Turn Therapeutics Inc. (NASDAQ:TTRX) Shares Shorted: Short Interest Up 74.1% in September - MarketBeat | Turn Therapeutics Inc. (NASDAQ:TTRX) Shares Shorted: Short Interest Up 74.1% in September MarketBeat | View source ↗ | MarketBeat | Oct 15, 2026 | neutral | 0 | 0.6 |
| Turn Therapeutics Inc. (TTRX) Stock Forecasts - Yahoo Finance | Turn Therapeutics Inc. (TTRX) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 9, 2026 | neutral | 0 | 0.6 |
| Turn Therapeutics Inc. (NASDAQ:TTRX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat | Turn Therapeutics Inc. (NASDAQ:TTRX) Receives Consensus Rating of "Moderate Buy" from Brokerages MarketBeat | View source ↗ | MarketBeat | Oct 9, 2026 | neutral | 0 | 0.6 |
| Turn Therapeutics Inc. - Common Stock (Nasdaq:TTRX) Stock Quote - FinancialContent | Turn Therapeutics Inc. - Common Stock (Nasdaq:TTRX) Stock Quote FinancialContent | View source ↗ | FinancialContent | Oct 8, 2026 | neutral | 0 | 0.6 |
| An eczema trial is enrolling about 135 people as Turn Therapeutics (TTRX) awaits results. - Stock Titan | An eczema trial is enrolling about 135 people as Turn Therapeutics (TTRX) awaits results. Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| Turn Therapeutics (NASDAQ:TTRX) Cut to Sell at Wall Street Zen - MarketBeat | Turn Therapeutics (NASDAQ:TTRX) Cut to Sell at Wall Street Zen MarketBeat | View source ↗ | MarketBeat | Sep 26, 2026 | neutral | 0 | 0.6 |
| Turn Therapeutics (NASDAQ:TTRX) Stock Rating Upgraded by Lucid Cap Mkts - MarketBeat | Turn Therapeutics (NASDAQ:TTRX) Stock Rating Upgraded by Lucid Cap Mkts MarketBeat | View source ↗ | MarketBeat | Sep 25, 2026 | neutral | 0 | 0.6 |
| TTRX: Turn Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits | TTRX: Turn Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideas Stocktwits | View source ↗ | Stocktwits | Sep 18, 2026 | neutral | 0 | 0.6 |
| Turn Therapeutics (TTRX) Surges 7.34% to $10.38 as Biotech Momentum Accelerates - Ichimoku Entry - siam.in | Turn Therapeutics (TTRX) Surges 7.34% to $10.38 as Biotech Momentum Accelerates - Ichimoku Entry siam.in | View source ↗ | siam.in | Sep 3, 2026 | neutral | 0 | 0.6 |
| TTRX Forecast — Price Target — Prediction for 2027 - TradingView | TTRX Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jul 26, 2026 | neutral | 0 | 0.6 |
| Turn Therapeutics: Small Market Cap, Huge Potential (NASDAQ:TTRX) - Seeking Alpha | Turn Therapeutics: Small Market Cap, Huge Potential (NASDAQ:TTRX) Seeking Alpha | View source ↗ | Seeking Alpha | Jul 15, 2026 | neutral | 0 | 0.6 |
| Why Is Turn Therapeutics Stock Trading Higher Today? - Benzinga | Why Is Turn Therapeutics Stock Trading Higher Today? Benzinga | View source ↗ | Benzinga | Jul 7, 2026 | neutral | 0 | 0.6 |
| Turn Therapeutics stock rises on expanded dermatitis trial - Investing.com | Turn Therapeutics stock rises on expanded dermatitis trial Investing.com | View source ↗ | Investing.com | Jul 7, 2026 | neutral | 0 | 0.6 |
| Turn Therapeutics broadens GX-03 trial after interim data in dermatitis - Stock Titan | Turn Therapeutics broadens GX-03 trial after interim data in dermatitis Stock Titan | View source ↗ | Stock Titan | Jul 7, 2026 | neutral | 0 | 0.6 |
| Turn Therapeutics stock rises on expanded dermatitis trial By Investing.com - Investing.com Nigeria | Turn Therapeutics stock rises on expanded dermatitis trial By Investing.com Investing.com Nigeria | View source ↗ | Investing.com Nigeria | Jul 7, 2026 | neutral | 0 | 0.6 |
| Turn Therapeutics Insiders May Regret Not Buying More, Market Cap Hits US$217m - Simply Wall Street | Turn Therapeutics Insiders May Regret Not Buying More, Market Cap Hits US$217m Simply Wall Street | View source ↗ | Simply Wall Street | Jul 1, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Oct 8, 2025 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.